RTX
Showing 1 - 25 of 144
Vertical Alveolar Bone Loss Trial in Mansoura (surgical placement of long dental implants, overdenture supported by RTX
Completed
- Vertical Alveolar Bone Loss
- surgical placement of long dental implants
- overdenture supported by RTX attachment system
-
Mansoura, EgyptChristine Ibrahim
Mar 11, 2022
Osteoarthritis Trial in Barranquilla (RTX-GRT7039)
Not yet recruiting
- Osteoarthritis
-
Barranquilla, Atlántico, ColombiaCentro de Investigación Médico Asistencial S.A.S - CIMEDICAL S.A
May 12, 2022
Phenylketonurias Trial in Aurora (RTX-134)
Active, not recruiting
- Phenylketonurias
-
Aurora, ColoradoChildren's Hospital Colorado
Jan 6, 2022
Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorders
- (no location specified)
Sep 29, 2023
APS Secondary to SLE
Recruiting
- Antiphospholipid Syndrome
- Telitacicept
- +5 more
-
Jinan, Shandong, ChinaQilu Hospital
Nov 30, 2022
Rheumatoid Arthritis, Remission Trial in Vienna (500mg RTX Group, 1000mg RTX Group)
Terminated
- Rheumatoid Arthritis
- Remission
- 500mg RTX Group
- 1000mg RTX Group
-
Vienna, AustriaMedical University of Vienna
Nov 2, 2021
Cancer Patients Receiving Stereotactic Body RTX Trial in Dallas (SBRT)
Recruiting
- Cancer Patients Receiving Stereotactic Body RTX
- SBRT
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Aug 25, 2022
Pain, Intractable, Pain Cancer, Pain Trial in Bellaire (Resiniferatoxin, Placebo)
Recruiting
- Pain, Intractable
- +2 more
- Resiniferatoxin
- Placebo
-
La Jolla, California
- +3 more
Feb 2, 2023
Ophthalmopathy, Thyroid-Associated Trial in Gothenburg, Mölndal, Stockholm (Rituximab, Iv Methylprednisolone, peroral
Active, not recruiting
- Ophthalmopathy, Thyroid-Associated
- Rituximab
- +2 more
-
Gothenburg, Sweden
- +4 more
Sep 17, 2021
Osteoarthritis, Knee, Knee Osteoarthritis, Knee Pain Chronic Trial in United States (Resiniferatoxin, Zilretta, Placebo)
Recruiting
- Osteoarthritis, Knee
- +2 more
- Resiniferatoxin
- +2 more
-
La Mesa, California
- +5 more
Mar 24, 2022
Pain, Intractable, Pain Cancer Trial (Resiniferatoxin, Standard of Care)
Withdrawn
- Pain, Intractable
- Pain Cancer
- Resiniferatoxin
- Standard of Care
- (no location specified)
Nov 2, 2021
Osteoarthritis, Knee, Knee Pain Chronic Trial (Resiniferatoxin, Placebo)
Withdrawn
- Osteoarthritis, Knee
- Knee Pain Chronic
- Resiniferatoxin
- Placebo
- (no location specified)
Nov 2, 2021
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER Trial in United States (NAB-PACLITAXEL, PACLITAXEL)
Completed
- STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
-
Rochester, New York
- +4 more
Oct 5, 2021
Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Beijing (Raltitrexed, Paclitaxel)
Completed
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
-
Beijing, ChinaChinese Academy of Medical Sciences
Jan 29, 2021
Osteoarthritis, Knee, Pain, Knee Trial in United States (Resiniferatoxin, Saline)
Completed
- Osteoarthritis, Knee
- Pain, Knee
-
Los Angeles, California
- +3 more
Mar 30, 2021
Morton's Neuroma Trial run by the National Institutes of Health Clinical Center (CC) (Resiniferatoxin)
Not yet recruiting
- Morton's Neuroma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 31, 2023
Intractable Pain, Palliative Care Trial run by the NINDS (Resiniferatoxin)
Not yet recruiting
- Intractable Pain
- Palliative Care
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Membranous Nephropathy - PLA2R Induced Trial in Saint Petersburg (Rituximab, Cyclophosphamide, and Corticosteroids)
Recruiting
- Membranous Nephropathy - PLA2R Induced
- Rituximab, Cyclophosphamide, and Corticosteroids
-
Saint Petersburg, Russian FederationSt. Petersburg State Pavlov Medical University
Jan 7, 2023
Diffuse Large B-cell Lymphoma Trial in Worldwide (Rituximab (RTX), Tafasitamab, Bendamustine (BEN))
Active, not recruiting
- Diffuse Large B-cell Lymphoma
- Rituximab (RTX)
- +2 more
-
Anaheim, California
- +157 more
Aug 1, 2022